Defecetive Drugs: adrugrecall.com

NEWS®

We Can Help.

Contact Us Today

Use this form to request a free consultation with a qualified attorney near you.

ATTORNEY ADVERTISING -

Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.

SEC requests Celebrex, Bextra data

August 9, 2005

The Securities and Exchange Commission requested information and documents on Pfizer Inc.'s Celebrex and Bextra painkillers in the second quarter, according to a company filing.

Pfizer is the world's biggest drugmaker but has been facing public scrutiny over its two Cox-2 inhibitor drugs ever since Merck & Co. announced it was withdrawing its similar drug Vioxx from the market last September. Vioxx was linked to double the risk of heart attacks and stroke when used for 18 months or longer.

Bextra was also pulled from the market because of safety risks in April. The U.S. Food and Drug Administration ordered Pfizer and 19 other popular prescription competitors to provide stronger drug warnings about possible cardiovascular risks in pain relievers.

Similar requests for information and documents have been made from the Department of Justice and a group of state attorneys generals regarding Celebrex and Bextra. The latest SEC request did not come as a surprise to analysts.

For more information on Celebrex and Bextra, please contact us to confer with a Celebrex Lawyer or Bextra Lawyer and learn your legal rights and options.

More Recent Defective Drug News

More Issues

Legal Marketing Website designed and developed by: eJustice.com

ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.